Literature DB >> 15718119

Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.

Duska M Franic1, Dev S Pathak, Amiram Gafni.   

Abstract

OBJECTIVE: We investigated the relationship between quality-adjusted life years (QALYs) and willingness to pay (WTP) in acute and chronic conditions. STUDY DESIGN AND
SETTING: Face-to-face interviews were used to collect data in a convenience sample of women. Participants completed one interview evaluating preferences for an acute condition, post-chemotherapy nausea and vomiting (PCNV), and the other interview for a chronic condition (breast cancer). Preferences were elicited for QALYs using visual analogue scale (VAS), and standard gamble in addition to WTP. Because QALYs and WTP are purportedly based on the same underlying theoretical foundations, WTP was regressed onto change in QALYs, age, income, and health status.
RESULTS: Regression analysis reported statistically significant models for all breast cancer (P < .001) and PCNV (P < .05) conditions tested. However, QALY was not a significant predictor of WTP.
CONCLUSION: The results of this study indicate QALYs was a poor predictor of WTP for the conditions tested. Linear combinations of change in QALYs, age, income, and health status were a better predictor of WTP for chronic than acute conditions. This can be attributed to violations of underlying assumptions in measurement of QALYs with acute conditions and to problems with the use of WTP with chronic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718119     DOI: 10.1016/j.jclinepi.2004.10.005

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.

Authors:  Christian R C Kouakou; Thomas G Poder
Journal:  Eur J Health Econ       Date:  2021-08-21

2.  Willingness-to-pay for cancer treatment and outcome: a systematic review.

Authors:  Alene Sze Jing Yong; Yi Heng Lim; Mark Wing Loong Cheong; Ednin Hamzah; Siew Li Teoh
Journal:  Eur J Health Econ       Date:  2021-12-02

3.  Health state utilities for metastatic breast cancer.

Authors:  A Lloyd; B Nafees; J Narewska; S Dewilde; J Watkins
Journal:  Br J Cancer       Date:  2006-09-18       Impact factor: 7.640

Review 4.  A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?

Authors:  Khachapon Nimdet; Nathorn Chaiyakunapruk; Kittaya Vichansavakul; Surachat Ngorsuraches
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

5.  Plastic stents are more cost-effective than lumen-apposing metal stents in management of pancreatic pseudocysts.

Authors:  Yen-I Chen; Mouen A Khashab; Viviane Adam; Ge Bai; Vikesh K Singh; Majidah Bukhari; Olaya Brewer Gutierrez; B Joseph Elmunzer; Robert A Moran; Lea Fayad; Mohamad El Zein; Vivek Kumbhari; Alessandro Repici; Alan N Barkun
Journal:  Endosc Int Open       Date:  2018-07-04

Review 6.  Understanding the global measurement of willingness to pay in health.

Authors:  Jean A McDougall; Wesley E Furnback; Bruce C M Wang; Jörg Mahlich
Journal:  J Mark Access Health Policy       Date:  2020-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.